Extending the Validity of your IVDD Certificates – Key Dates

Kamiya Crabtree
A team of profesional-looking people sit around a table, congratulating themselves.

The EU and the MHRA have extended the validity of IVDD certificates, allowing you more time to transition to the IVDR. In this article, Kamiya Crabtree explains what this means for you.

Recently, the EU has extended the validity of EU IVDD (In Vitro Diagnostic Medical Device Directive) certificates and declarations. The EU has updated the timelines for IVD devices to align with the EU In Vitro Diagnostic Devices Regulation (2017/746) (EU IVDR). As a result, devices with EU IVDD certificates will now be allowed to remain on the EU market for a longer period of time.

Previously, IVDD CE certificates and declarations of conformity were set to expire on 26th May 2025. Under the updated transitional provisions, the validity of certain certificates and declarations has been extended as follows:

Device classification New deadline Applies as long as…
Annex II List A devices 31st December 2027 The CE certificate was issued after 25th May 2017 and was still valid on 26th May 2022.
Annex II List B devices
Self-test devices
General IVD devices that have been upclassified to Class D IVD devices The declaration of conformity was drawn up before 26th May 2022.
General IVD devices that have been upclassified to Class C IVD devices 31st December 2028
General IVD devices that have been upclassified to Class B IVD devices 31st December 2029
Class A devices placed on the market in a sterile condition

Key points to note:

  • Notified Bodies are not required to change the date on the individual certificates
  • The above dates are subject to meeting the relevant conditions under EU IVDR Article 110(3c)
  • If your device is being placed on both the GB and NI markets, you should upload a single declaration confirming that the Article 110 extended CE certificate validity applies to both markets.

Unsure which IVDR classification applies to your product? Find out more about what the new classification system means for you.

Extended validity in the UK

The MHRA (Medicines and Healthcare products Regulatory Agency) has issued new guidance on the impact of these new deadlines on the UK.

Great Britain (GB) – England, Wales, and Scotland

To support the safe supply of medical devices to GB and make the transition to the new regulatory framework smoother, the government has put in place legislation that extends the acceptance of CE-marked IVD devices. This means that CE-marked IVD devices, whether compliant with the EU IVDD or the EU IVDR, can continue to be placed on the GB market until the 30th June 2030 (or until the certificate expires).

This is great news because it allows certain devices to stay on the market longer. However, there’s a key limitation: general IVD devices that were previously not required to involve a Notified Body under the EU IVDD will only be allowed on the GB market if they are upclassified (meaning the involvement of a Notified Body is now required under the EU IVDR).

It’s also important to note that manufacturers won’t be able to use expired certificates, unless the EU has deemed them valid under specific conditions.

So, if you’re relying on an EU IVDD CE certificate with extended validity under Article 110 to place devices on the GB market, be sure to update the MHRA Device Online Registration System as outlined in the guidance. The devices can stay on the market until the 30th June 2030 (or until the certificate expires).

Northern Ireland (NI)

The rules for placing IVD devices on the NI market are different from those for GB. Since 26th May 2022, the EU IVDR has applied in both EU Member States and Northern Ireland.

CE certificates with extended validity under the EU IVDR transitional arrangements (Article 110) can still be used to place devices on the NI market, as long as EU IVDD CE-marked medical devices are accepted.

For these devices to be valid on the NI market, they must meet the conditions set out in Article 110(3c), including:

  • Continued compliance with Directive 98/79/EC
  • No significant changes to the design or intended purpose
  • No unacceptable risk to the health or safety of patients, users, or others, or to public health protection

Additionally, there are some important steps you must follow:

  • By 26th May 2025, you’ll need to provide evidence that you’ve implemented a quality management system in accordance with EU IVDR Article 10(8).
  • By 26th May 2025, you’ll also need to provide evidence that you or your authorised representative have made a formal application to a Notified Body.
  • By 26th September 2025, you must provide evidence that both the Notified Body and the manufacturer have signed a written agreement.

If you plan to rely on an EU IVDD CE certificate with extended validity under Article 110 for placing devices on the NI market, the MHRA encourages you to reflect this on the MHRA Device Online Registration System.

Previously expired certificates

If you want to rely on a certificate that expired before 9th July 2024 but was still valid on 26th May 2022, you must upload a letter from the Notified Body. This letter should confirm that they’ve received the manufacturer’s application for conformity assessment and that a written agreement has been finalised.

Alternatively, you could upload a completed template instead of the letter, which should declare that the key conditions for extending the certificate under EU IVDR Article 110 have been met. These conditions include:

  • A signed contract with the Notified Body that was in place before the certificate expired, or
  • If no contract existed at the time of expiry, confirmation that the manufacturer had received a derogation from conformity assessment procedures under Article 54(1) of the EU IVDR, or
  • Confirmation that they were allowed extra time to complete the conformity assessment as per Article 92(1) of the EU IVDR.

Certificates expiring on or after 9th July 2024

If you intend to rely on a certificate that was valid on 26th May 2022 and has expired on or after 9th July 2024, you must upload a letter from the Notified Body confirming that they have received the manufacturer’s application for conformity assessment and that a written agreement has been finalised.

Alternatively, instead of the letter, you can upload a declaration stating that the certificate remains valid under EU IVDR Article 110.

Final thoughts

Navigating the evolving landscape of IVDR compliance can be complex. These updated guidelines offer crucial clarity, streamlining the process and ensuring your devices maintain market access. From extended certificate validity to essential documentation, staying informed is key.

Following these guidelines will help ensure the ongoing safety, quality, and regulatory compliance of your IVD products. To successfully navigate the transition to IVDR, be sure to explore our latest article for an in-depth guide on what steps you need to take.

Stay informed on the latest IVDR updates and their potential impact by subscribing to our newsletter below.

Back to top

Related articles

  1. A team of profesional-looking people sit around a table, congratulating themselves.

    GSPR 1: A New Era of Performance with Safety at the Core

    This regulation emphasizes risk management, durable design & biocompatibility to ensure medical devices are safe and effective. GSPR 1 protects users while driving innovation in medical technology.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer

  2. Cybersecurity Vulnerabilities in Medical Devices: FDA Alerts on Contec and Epsimed Monitors

    Patients can be exposed to risks when devices are online. We explore implications for EU MDR/IVDR cybersecurity requirements, including MDCG guidance

    Dr Clare Dixon Dr Clare Dixon Regulatory Specialist
  3. A futuristic-looking factory full of labelled cardboard boxes.

    Decoding UDI: Your Ultimate Guide to Smarter Medical Device Labelling

    The Unique Device Identifier (UDI) ensures medical device traceability and compliance. We break down its structure, Device Identifier (UDI-DI), Production Identifier (UDI-PI) and its role in EUDAMED.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  4. A scientist uses a pipette to prepare lab samples.

    Understanding Risk-Based Classification of In Vitro Medical Devices Under EU IVDR

    The transition from IVDD replaces list-based classification with a risk-based approach. Manufacturers must thoroughly understand the rules outlined in Annex VIII of the IVDR.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  5. A medical team discuss performance data at their desktop computer.

    Key Updates for Navigating EMDN: MDCG 2024-2 Rev.1 & 2021-12 Rev.1

    Release of the updated guidance helps manufacturers navigate the EMDN system for accurate device classification, ensuring market access.

    Ron Sangal Ron Sangal Lead Medical Writer
  6. A lab technician enters samples into a machine.

    From IVDD to IVDR: Ensuring Compliance During the Transitional Period

    Legacy device manufacturers need to manage challenging timelines as well as address transitional provisions and update QMS.

    Shona Richardson Shona Richardson Regulatory Medical Writer
  7. A dated monitor for medical equipment.

    Understanding Clinical Evidence Requirements with MDCG 2020-6

    How can manufacturers ensure legacy devices meet MDR's stringent requirements? Discover how MDCG 2020-6 guidance simplifies the path to compliance.

    Dr Clare Dixon Dr Clare Dixon Regulatory Specialist
  8. A stethoscope laid on a desk of regulatory documentation.

    Clinical benefits of an in vitro diagnostic medical device

    How to determine the clinical benefit of an IVD and successfully incorporate it into regulatory documentation.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  9. EU flags

    Regulation (EU) 2024/1860 - Its impact on EU MDR and IVDR

    How does the recent Regulation (EU) 2024/1860 amendment affect the EU MDR & IVDR?

    Shona Richardson Shona Richardson Regulatory Medical Writer
  10. EU flag

    MDCG 2024-10 - Orphan medical devices

    How to apply MDR pre-market clinical evidence requirements to medical devices intended for limited usage.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  11. Considering a medical device's intended purpose

    A medical device's intended purpose - what is the point?

    How do you define intended purpose, indication for use, intended clinical benefits, and claims?

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  12. Mantra Systems presents EnableChat, your AI-powered MDR & MDCG chatbot

    EnableChat - Your AI-powered MDR and MDCG chatbot

    Search the MDR and MDCG documents in seconds by asking EnableChat your questions.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  13. Searching adverse event databases for vigilance data

    Staying vigilant - A guide to searching for adverse events data

    We discuss the pros and cons of existing adverse event databases for vigilance data searching.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  14. A doctor reading an SSCP document with a patient

    What is Summary of Safety and Clinical Performance (SSCP)?

    We explain what the SSCP is, when you'll need it and what its objectives are.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  15. A woman in a laboratory looking down a microscope

    Scientific Validity Reports – Foundation of the IVDR Performance Evaluation

    Justifying scientific validity is the first step in proving compliance with the IVDR.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  16. A pile of question marks

    Medical Device 'Significant Changes' – Navigating EU MDR Article 120(3) using MDCG 2020-3 rev. 1

    Understand what changes to your medical device are considered 'significant' under EU MDR (2017/745).

    Shen May Khoo Shen May Khoo Junior Regulatory Specialist
  17. A signpost giving unsure directions

    MDR or IVDR - A sibling rivalry?

    A guide to easily understanding whether your device is a medical device or an in vitro diagnostic medical device (IVD).

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  18. An EU and UK flag

    What the latest Brexit U-turn means for CE Marking of medical devices in Great Britain

    Will Great Britain continue to allow the use of the CE mark for medical devices beyond the 2024 deadline?

    Dr Hanna Gul Dr Hanna Gul Lead Medical Writer
  19. A woman writing her own medical device regulation documentation

    Gain confidence, reassurance and control over your EU MDR strategy

    Find out how to build your own technical files within a guided framework while minimising financial outlays.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  20. Racing to achieve MDR compliance

    Still racing to achieve MDR compliance? A transition period update

    On January 6th 2023, the EU commission has adopted the proposal to extend the transition rules of the EU MDR.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  21. A 7-step guide to navigating regulatory requirements for medical device start-ups

    A medical device regulations guide for start-up companies

    We present a 7-step guide to navigating regulatory requirements on a budget.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  22. An update on UKCA Marking of Medical Devices

    UKCA Marking of Medical Devices – An update on the status quo

    We review recently updated requirements for UKCA marking and what it means for your regulatory strategy.

    Dr Hanna Gul Dr Hanna Gul Lead Medical Writer
  23. How to choose a CER writer for your MDR Clinical Evaluation

    Choosing a CER writer for your MDR Clinical Evaluations

    We've compiled a list of considerations that will help you make the right choice when choosing a CER writer.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  24. Achieving MDR Compliance for Class I medical devices

    How to achieve MDR Compliance for Class I medical devices

    We outline a strategy for the regulatory compliance of Class I medical devices.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  25. Literature Search, SOTA Review and Clinical Evaluation

    Literature Search, SOTA Review process and Clinical Evaluation

    We help to demystify the process of systematic search & review of literature for Clinical Evaluation.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  26. Literature Search Protocols & SOTA Reviews for medical devices and what to know before you start

    Literature searches and reviews for medical devices - what to know before you start

    We explain what you should know before beginning a literature search & review for your medical device.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  27. Five useful resources when writing a medical device CER

    Five useful resources when writing a medical device CER

    We outline five of the most useful and trustworthy Clinical Evaluation Report writing resources.

    Dr Victoria Cartwright Dr Victoria Cartwright Relationship Manager
  28. Avoid pitfalls when writing a Clinical Evaluation Report

    Five common pitfalls when writing a Clinical Evaluation Report

    We illustrate five pitfalls when writing CERs and give you some tips to overcome them.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  29. How to make a medical device equivalence claim under the MDR

    Five tips for making a medical device equivalence claim under the MDR

    We'll show you what to keep in mind with regards to equivalance and Clinical Evaluation.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  30. Keeping medical devices in market and maintaining CE-marks - a guide to effective data collection

    Keeping medical devices in market and maintaining CE-marks

    The 4 golden rules to drive regulatory compliance with PMCF and vigilance data collection.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  31. How PMCF goes beyond simple compliance - improving products and engaging customers

    How PMCF goes beyond simple compliance

    The wider benefits of a well-designed PMCF system include improving your products and your relationship with your clients.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  32. PMCF systems for medical devices

    Why you'll almost certainly need a PMCF system for your medical devices

    We tell you what to be aware of under the EU MDR regarding PMCF and your medical devices.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  33. Ensure medical device regulatory compliance of your devices through Brexit

    The impact of Brexit on medical device regulatory compliance

    How to ensure regulatory alignment of your devices in the territories affected by Brexit.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  34. Use medical device regulatory consulting services to supercharge your MDR transition

    Is outside consulting support the answer to your MDR transition?

    Getting ready for the MDR is a demanding process. Outsourcing might be your solution.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  35. Increasing data entry compliance in PMCF studies

    Increasing data entry compliance in PMCF studies

    5 methods every medical device manufacturer should know to improve their Post-Market Clinical Follow-up studies.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  36. Why medical doctors can drive MDR compliance

    Why medical doctors can drive MDR compliance

    Working with the MDR requires knowing how to work with clinical evidence. Medical doctors are perfectly positioned to meet this requirement.

    Dr Victoria Cartwright Dr Victoria Cartwright Relationship Manager
  37. Software as a Medical Device

    Software as a Medical Device

    Unless you have spent time working with medical device legislation in the past, the idea that software could be a medical device may be rather unexpected.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  38. clinical investigator for pmcf eu mdr compliance

    Ensuring that clinical investigations work in practice

    How can medical device manufacturers ensure valid clinical investigations when access to medical expertise remains limited?

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  39. Coronavirus and medical device regulations

    Relaxing medical device regulatory requirements during a healthcare crisis

    During the coronavirus pandemic, how far should we go when relaxing medical device regulatory requirements?

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  40. The new MDR compliance challenge

    The new MDR compliance challenge

    Across the industry, medical device companies are facing challenges in meeting the demands of the new Medical Device Regulations (MDR) 2017/745 framework.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  41. Sources of Real World Evidence for MDR compliance

    Sources of Real World Evidence for MDR compliance

    At Mantra Systems our objective is to make sure that our clients choose the method of real world data harvesting that is right for them.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer

More articles

Do you need support with your medical device approval strategy?

Contact us today